Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
MEDOFLORAN 250 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. For oral administration. White, round, flat, scored tablet, with diameter 10.5 mm. The tablet can be divided into equal doses. |
Each tablet contains terbinafine HCL equivalent to 250 mg terbinafine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Terbinafine |
Terbinafine is an allylamine which has a broad spectrum of antifungal activity. Terbinafine acts by inhibition of squalene epoxidase in the fungal cell membrane. At low concentrations terbinafine is fungicidal against dermatophytes, moulds and certain dimorphic fungi. The activity versus yeasts is fungicidal or fungistatic depending on the species. |
| List of Excipients |
|---|
|
Sodium starch glycollate, HPMC E5, microcrystalline cellulose 101, colloidal silicon dioxide, magnesium stearate |
PVC-A1 blisters of 7 tablets each. Packs of 14 and 28 tablets are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
20373
17/07/08
| Drug | Countries | |
|---|---|---|
| MEDOFLORAN | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
